Subject: Questions about GRID implementation validation

From: "Tensfeldt, Thomas G" <thomas_g_tensfeldt=at=groton.pfizer.com>
Date: Sun, 8 Feb 2004 22:11:02 -0500

All,
I'd be very interested in individual and institutional experience with the
validation/qualification of GRID based systems for scientific computing. A
working group is beginning to develop a document that will serve as a
guideline/white paper for implementation of GRID systems for
Pharmacokinetic/Pharmacodynamic modeling. 

Before reinventing the wheel, we'd like to ask people who may already have
extensive experience with this and have similar guidelines in place already.
Any information along these lines would be welcome. I'll gladly summarize
for the list.

TIA,
Tom Tensfeldt
Pfizer Global Research & Development

LEGAL NOTICE
Unless expressly stated otherwise, this message is confidential and may be privileged. It is intended for the addressee(s) only. Access to this E-mail by anyone else is unauthorized. If you are not an addressee, any disclosure or copying of the contents of this E-mail or any action taken (or not taken) in reliance on it is unauthorized and may be unlawful. If you are not an addressee, please inform the sender immediately.